Profiel
Mark T.
Marino held several positions in the pharmaceutical industry, including Senior VP-Research & Clinical Operations at MannKind Corp., Head-Clinical Pharmacology at Eisai, Inc., Vice President at Daiichi Sankyo, Inc., and Chief Medical Officer at Imugene Ltd.
He also worked as an Associate Professor at the Uniformed Services University of the Health Sciences and Head-Pharmacology at the Walter Reed Army Institute of Research.
Marino received his undergraduate degree from the US Military Academy and his doctorate from Albert Einstein College of Medicine, Inc.
Eerdere bekende functies van Mark T. Marino
| Bedrijven | Functie | Einde |
|---|---|---|
| IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 30-09-2020 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
| Roche Corp. | Corporate Officer/Principal | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Opleiding van Mark T. Marino
| US Military Academy | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| IMUGENE LIMITED | Health Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
| Walter Reed Army Institute of Research | |
| Roche Corp. |
